BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36155216)

  • 1. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR.
    Wang R; Li S; Chen P; Yue X; Wang S; Gu Y; Yuan Y
    Phytomedicine; 2022 Dec; 107():154435. PubMed ID: 36155216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
    Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
    Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA GAS5 restrains CCl
    Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
    Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
    Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
    Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
    J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis.
    Dong Z; Li S; Si L; Ma R; Bao L; Bo A
    Eur J Clin Invest; 2020 Jun; 50(6):e13243. PubMed ID: 32306379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433-3p/TLR10 axis.
    Su SB; Tao L; Liang XL; Chen W
    Dig Liver Dis; 2022 Aug; 54(8):1066-1075. PubMed ID: 34903500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.
    Yu F; Lu Z; Chen B; Wu X; Dong P; Zheng J
    J Cell Mol Med; 2015 Nov; 19(11):2617-32. PubMed ID: 26257392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
    Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
    BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
    Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
    Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.
    Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J
    Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ.
    Liu F; Li S; Chen P; Gu Y; Wang S; Wang L; Chen C; Wang R; Yuan Y
    Int Immunopharmacol; 2023 Sep; 122():110550. PubMed ID: 37451016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.